Have any of you participated in a very small (phase 1) clinical trial in Texas?

[donits]

Researchers at the University of Texas MD Anderson Cancer Center led the development of a GLS1 inhibitor that is now showing in patients with a variety of solid tumor types. Only 20 patients from the USA participated and 60% of them responded well to this attempt.

I hope that further trials will be continued.

[TheTopBanana]

Interesting! Thanks for posting!

[donits in reply to TheTopBanana]

Thank you for your interest in the topic

[6357axbz]

Did this trial include PCa?

[donits in reply to 6357axbz]

I am not sure if there were prostate cancer patients in this study. The information stated: ..." The drug, a small molecule dubbed IACS-6274 tested in a phase 1 trial involving the type of lung cancer, ovarian cancer, and solid tumors..."